drugset

drugset / Trial / NCT01014962

A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus

NCT01014962 ↗

Phase 1 Completed 24 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab

RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this study is to determine an upper dose of albaconzole to be administered in a Thorough QTc study.

Timeline

Start: 2009-08-24
Primary completion: 2009-12-04
Completion: 2009-12-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Albaconozole	Unknown	400 mg	Oral

Indications